Share this page | Email | Contact Us

Special Report on

The Patent Medicine Situation

the patent medicine situation special research report Photo by 1.bp.blogspot.com
The off patent drugs refer to a kind of copy drug, which have the same dosage, security, strength, quality, performance and intended uses to the commercial name drugs. The legal acquirement of the off patent drugs approximately concludes two situations: one is the pharmaceutical copy after the patent expiration; the other is the government obtains the production of the off patent drugs by means of compulsory license in the field of patent drugs relate to the public health. As the gradual reduction in the approved patent drugs in the market in the world, the development pace of the potent drugs is restrained. The patent ...
practices originating in China. Although well accepted in the mainstream of medical care throughout East Asia, it is considered an alternative medical system in much of the Western world. TCM practices include such treatments as Chinese herbal medicine, acupuncture , dietary therapy, and both Tui na and Shiatsu massage. Qigong and Taijiquan are also closely associated with TCM. TCM claims to be thousands of years old and is rooted in meticulous observation of how nature, the cosmos, and the human body are interacting. Major theories include; Yin-yang , the Five Phases , the human body Meridian/Channel system, Zang Fu organ ...
REVIEWS AND OPINIONS
Did Washington Post's Rob Stein exaggerate negative stories about ...
I mentioned last week on Genetic Future that a reporter with the Washington Post, Rob Stein, had emailed the National Society of Genetic Counsellors to search specifically for people with negative experiences of personal genomics for an upcoming article on the industry. At the time I called for personal genomics customers with positive experiences to email Stein, to ensure that he had a balanced view of the industry's impact. However, Stein did manage to find some negative stories from personal genomics customers, all of which center around the mistake made by LabCorp back in June that resulted in incorrect data being ... market research, surveys and trends
Fiber-optic cable - US Patent 7760977 Description
The present invention relates to step-index optical fibers composed of multicomponent glass containing a lanthanum-containing or a lanthanum-free core glass and a cladding glass that completely encloses the core glass on its circumferential wall. Furthermore, the invention relates to a fiber-optic cable for conducting electromagnetic radiation, containing at least one bundle of individual fibers, wherein the individual fibers contain step-index optical fibers composed of multicomponent glasscontaining a core glass and a cladding glass that completely encloses the core glass on its circumferential wall. For data transmission ... market research, surveys and trends

SURVEY RESULTS FOR
THE PATENT MEDICINE SITUATION

History of Legislative Control Over Opium, Cocaine, and Their ...
Legislative control over dangerous drugs may be dated from attempts in the nineteenth century to prevent acute poisoning by certain substances that might be purchased in ignorance of their lethal potential or might be too easily available to would-be suicides. Opium was being sold in a crude form containing about 10 percent morphine, as well as in concoctions derived from crude opium: paregoric, laudanum, and a solution in acetic acid known as "black drop." Morphine had been isolated from opium in 1805 by the German pharmacist, F. W. Serturner, but production of the powerful active ingredient of opium on a large scale was ... industry trends, business articles and survey research
The Situation in 1900 - History of the Non-Medical Use of Drugs
If you are interested in the non-medical use of drugs in this country, the time to go back to is 1900, and in some ways the most important thing I am going to say to you guys I will say first.  That is, that in 1900 there were far more people addicted to drugs in this country than there are today.  Depending upon whose judgment, or whose assessment, you accept, there were between two and five percent of the entire adult population of the United States addicted to drugs in 1900.      Now, there were two principal causes of this dramatic level of drug addiction at the turn of the ... industry trends, business articles and survey research
RELATED NEWS
Does Sousa story prove Rhee is right?
My colleague Stephanie McCrummen, a former Post foreign correspondent now on our education writing team, is not only a great journalist but has terrific timing. Her front page story today about rising test scores at Sousa Middle School in D.C. comes just at the local and national debate over the record of D.C. Schools Chancellor Michelle A. Rhee reaches a new peak. I wished her piece could have been longer. My wife, a veteran editor at another newspaper, looked at me when she heard that as if I were a small child asking for eight more bags of candy. But I am not indulging myself in this matter. McCrummen always goes deep in her ... market trends, news research and surveys resources
Gene Patenting Produces Profits, Not Cures
"How does it feel to be patented? There was a sense of betrayal. I mean, they owned a part of me that I could never recover. I certainly have no objection to scientific research ... but it was like a rape. In a sense, you've been violated, for dollars. My genetic essence is held captive." --John Moore, the subject of US Patent No. 4,438,032 Predictably, Myriad Genetics recently appealed a federal district court's recent decision rendering seven of its lucrative BRCA1 and BRCA2 gene patents invalid. The battle will probably run long, ending only when it reaches the Supreme Court, so the appeal raised hardly ... market trends, news research and surveys resources

INFORMATION RESOURCES

THE PATENT MEDICINE SITUATION.
The Patent Medicine Situation. "It is to be impressed on patients .... The Patent Medicine Situation. 10. The preparation must be in ... technology research, surveys study and trend statistics
NMAH | Object Groups
Patent medicines are named after the “letters patent” granted by the English crown. The first “letters patent” given to an inventor of a secret remedy was issued during the late 17th century. The patent granted the medicine maker a monopoly over his particular formula. The term “patent medicine” came to describe all pre-packaged medicines sold “over-the-counter” without a doctor’s prescription. In the United States very few preparations were ever actually patented. Many of the earliest English patent medicines, such as Turlington’s Balsam of Life, Bateman’s ... technology research, surveys study and trend statistics
REAL TIME
THE PATENT MEDICINE SITUATION
latest webinars
  1. Presenters
  2. Autumn 2006 Webcast - The Newsletter of the Sunderland & South ...
Join these Webinars to learn more about current research, trends and surveys.
QUESTIONS AND ANSWERS
Why is Marijuana criminalized in the U.S.? - Yahoo! Answers
I live in NJ and furious with there Compassionate Medical Marijuana Act which basically says you have to be dying to obtain medical marijuana. Also hate how they slandered CA medical marijuana situation. In my opinion every state should see CA as a role model and NJ as what not to do. This is paraphrased from Jello Biafra's spoken word "Grow More Pot" According to the U.S. Department of Agriculture you can make four times as much paper from one acre of hemp plants as you can from an acre of trees. So instead of chopping down all the redwoods, if you do it with hemp plants, you can just grow another crop a few months ...
How does a biosimilar differ from a generic drug? | LinkedIn ...
Biosimilars or follow-on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products, following patent expiry. A generic drug is a drug which is produced and distributed without patent protection. The generic drug may still have a patent on the formulation but not on the active ingredient. A generic must contain the same active ingredients as the original formulation. In most cases, generic products are available once the patent protections afforded to the original developer have expired. The U.S. FDA requires the bio-equivalence of the generic product to be between 80% and 125% ...